ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

ASHI Ashington Innovation Plc

1.20
0.00 (0.00%)
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Ashington Innovation Plc LSE:ASHI London Ordinary Share GB00BNM4K334 ORD GBP0.01
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 1.20 1.10 1.30 1.20 1.20 1.20 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Ashington Innovation PLC Dual Listing on the Frankfurt Stock Exchange (8349J)

21/08/2023 7:00am

UK Regulatory


Ashington Innovation (LSE:ASHI)
Historical Stock Chart


From May 2023 to May 2024

Click Here for more Ashington Innovation Charts.

TIDMASHI

RNS Number : 8349J

Ashington Innovation PLC

21 August 2023

Press Release

21 August 2023

Ashington Innovation plc

("Ashington" or "the Company")

Ashington Announces Dual Listing on the Frankfurt Stock Exchange

Ashington Innovation plc (LSE: ASHI), a special purpose acquisition company ("SPAC") established to acquire businesses primarily in the technology sector, is pleased to announce that it has received approval for its ordinary shares to commence trading on the Frankfurt Stock Exchange ("FSE") under the ticker symbol "6FW". Ashington's FSE information can be found on the Börse Frankfurt website: https://www.boerse-frankfurt.de/en .

The FSE is one of the world's largest international trading centres for securities. Operated by the Deutsche Börse Group, FSE is the largest of Germany's eight stock exchanges, and is responsible for approximately 90 percent of all securities traded in Germany. The FSE facilitates advanced electronic trading, settlement and information systems and enables cross-border trading for international investors.

Following the announcement of Ashington's proposed reverse takeover of Cell Therapy ("the Transaction") on 17 August 2023, the Company's ordinary shares are suspended pending the publication of a prospectus or an announcement that the Transaction is not proceeding.

Jason Smart, Founder of Ashington, said: "We are thrilled to announce the listing of our shares on the Frankfurt Stock Exchange. As one of the largest exchanges in the world, our dual-listing will enhance trading liquidity and facilitate investment in Ashington by institutional and retail investors across Europe."

For further information please contact:

 
 Ashington Innovation plc 
 David Orchard                         via Tancredi +44 207 887 
  General Counsel                       7633 
                                      ------------------------- 
 Tancredi Intelligent Communication 
  Media Relations 
                                      ------------------------- 
 Helen Humphrey 
  Charlie Hobbs                        + 44 7449 226 720 
  Jasmine Gadhavi                       +44 7897 557 112 
  ashington@tancredigroup.com           +44 7931 435 236 
                                      ------------------------- 
 

About Ashington Innovation plc

Ashington Innovation PLC is a special purpose acquisition company (SPAC), formed with the intention of acquiring businesses operating in the technology sector.

The Company believes that in the increasingly fast-changing global environment there will be an abundance of opportunities to acquire existing businesses in the technology sector, and in particular businesses that possess and utilise proprietary technologies and own applicable intellectual property.

The Company is not limited to any specific geographic region in identifying its target companies.

www.ashingtoninnovationplc.com .

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

MSCQVLFFXVLLBBZ

(END) Dow Jones Newswires

August 21, 2023 02:00 ET (06:00 GMT)

1 Year Ashington Innovation Chart

1 Year Ashington Innovation Chart

1 Month Ashington Innovation Chart

1 Month Ashington Innovation Chart